Logo image of DH

DEFINITIVE HEALTHCARE CORP (DH) Stock Fundamental Analysis

NASDAQ:DH - Nasdaq - US24477E1038 - Common Stock - Currency: USD

3.65  +0.02 (+0.55%)

After market: 3.65 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to DH. DH was compared to 36 industry peers in the Health Care Technology industry. The financial health of DH is average, but there are quite some concerns on its profitability. DH is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

DH had positive earnings in the past year.
In the past year DH had a positive cash flow from operations.
DH had negative earnings in each of the past 5 years.
Each year in the past 5 years DH had a positive operating cash flow.
DH Yearly Net Income VS EBIT VS OCF VS FCFDH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M -400M

1.2 Ratios

DH has a worse Return On Assets (-63.17%) than 80.56% of its industry peers.
DH has a Return On Equity of -158.26%. This is in the lower half of the industry: DH underperforms 72.22% of its industry peers.
Industry RankSector Rank
ROA -63.17%
ROE -158.26%
ROIC N/A
ROA(3y)-16.45%
ROA(5y)-10.62%
ROE(3y)-39.07%
ROE(5y)-24.71%
ROIC(3y)N/A
ROIC(5y)N/A
DH Yearly ROA, ROE, ROICDH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

The Gross Margin of DH (76.98%) is better than 83.33% of its industry peers.
In the last couple of years the Gross Margin of DH has remained more or less at the same level.
DH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 76.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.22%
GM growth 5Y0.01%
DH Yearly Profit, Operating, Gross MarginsDH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

4

2. Health

2.1 Basic Checks

DH does not have a ROIC to compare to the WACC, probably because it is not profitable.
DH has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, DH has more shares outstanding
DH has a worse debt/assets ratio than last year.
DH Yearly Shares OutstandingDH Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
DH Yearly Total Debt VS Total AssetsDH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

DH has an Altman-Z score of -0.19. This is a bad value and indicates that DH is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.19, DH is in line with its industry, outperforming 47.22% of the companies in the same industry.
DH has a debt to FCF ratio of 3.57. This is a good value and a sign of high solvency as DH would need 3.57 years to pay back of all of its debts.
The Debt to FCF ratio of DH (3.57) is better than 75.00% of its industry peers.
DH has a Debt/Equity ratio of 0.50. This is a neutral value indicating DH is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.50, DH is not doing good in the industry: 69.44% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 3.57
Altman-Z -0.19
ROIC/WACCN/A
WACC9.52%
DH Yearly LT Debt VS Equity VS FCFDH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.75 indicates that DH should not have too much problems paying its short term obligations.
DH has a Current ratio (1.75) which is in line with its industry peers.
A Quick Ratio of 1.75 indicates that DH should not have too much problems paying its short term obligations.
DH's Quick ratio of 1.75 is in line compared to the rest of the industry. DH outperforms 52.78% of its industry peers.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 1.75
DH Yearly Current Assets VS Current LiabilitesDH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

2

3. Growth

3.1 Past

DH shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
The Revenue has decreased by -3.05% in the past year.
DH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.15% yearly.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-37.5%
Revenue 1Y (TTM)-3.05%
Revenue growth 3Y14.91%
Revenue growth 5Y24.15%
Sales Q2Q%-6.76%

3.2 Future

Based on estimates for the next years, DH will show a decrease in Earnings Per Share. The EPS will decrease by -4.60% on average per year.
The Revenue is expected to decrease by -0.92% on average over the next years.
EPS Next Y-35.98%
EPS Next 2Y-13.05%
EPS Next 3Y-4.6%
EPS Next 5YN/A
Revenue Next Year-5.34%
Revenue Next 2Y-1.9%
Revenue Next 3Y-0.92%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DH Yearly Revenue VS EstimatesDH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
DH Yearly EPS VS EstimatesDH Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 11.41 indicates a reasonable valuation of DH.
Compared to the rest of the industry, the Price/Earnings ratio of DH indicates a rather cheap valuation: DH is cheaper than 100.00% of the companies listed in the same industry.
DH's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.31.
With a Price/Forward Earnings ratio of 13.79, DH is valued correctly.
DH's Price/Forward Earnings ratio is rather cheap when compared to the industry. DH is cheaper than 86.11% of the companies in the same industry.
DH is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.13, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.41
Fwd PE 13.79
DH Price Earnings VS Forward Price EarningsDH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

DH's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. DH is cheaper than 94.44% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DH indicates a rather cheap valuation: DH is cheaper than 94.44% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 11.15
EV/EBITDA 9.22
DH Per share dataDH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

DH's earnings are expected to decrease with -4.60% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.05%
EPS Next 3Y-4.6%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DEFINITIVE HEALTHCARE CORP

NASDAQ:DH (6/13/2025, 8:00:01 PM)

After market: 3.65 0 (0%)

3.65

+0.02 (+0.55%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners37.16%
Inst Owner Change-2.43%
Ins Owners7.23%
Ins Owner Change46.83%
Market Cap534.14M
Analysts72.73
Price Target4.18 (14.52%)
Short Float %10.46%
Short Ratio3.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)55.61%
Min EPS beat(2)9.63%
Max EPS beat(2)101.59%
EPS beat(4)4
Avg EPS beat(4)33.45%
Min EPS beat(4)0.72%
Max EPS beat(4)101.59%
EPS beat(8)6
Avg EPS beat(8)25.39%
EPS beat(12)10
Avg EPS beat(12)27.98%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.05%
Min Revenue beat(2)-0.19%
Max Revenue beat(2)2.29%
Revenue beat(4)1
Avg Revenue beat(4)-0.34%
Min Revenue beat(4)-2.09%
Max Revenue beat(4)2.29%
Revenue beat(8)1
Avg Revenue beat(8)-1.45%
Revenue beat(12)2
Avg Revenue beat(12)-1.16%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-9.89%
PT rev (3m)-16.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-32.64%
EPS NY rev (1m)0%
EPS NY rev (3m)-26.35%
Revenue NQ rev (1m)0.24%
Revenue NQ rev (3m)-1%
Revenue NY rev (1m)0.09%
Revenue NY rev (3m)0.6%
Valuation
Industry RankSector Rank
PE 11.41
Fwd PE 13.79
P/S 2.15
P/FCF 11.15
P/OCF 7.89
P/B 1.65
P/tB N/A
EV/EBITDA 9.22
EPS(TTM)0.32
EY8.77%
EPS(NY)0.26
Fwd EY7.25%
FCF(TTM)0.33
FCFY8.97%
OCF(TTM)0.46
OCFY12.67%
SpS1.69
BVpS2.21
TBVpS-1.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -63.17%
ROE -158.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 76.98%
FCFM 19.32%
ROA(3y)-16.45%
ROA(5y)-10.62%
ROE(3y)-39.07%
ROE(5y)-24.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.22%
GM growth 5Y0.01%
F-Score3
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 3.57
Debt/EBITDA 3.65
Cap/Depr 37.47%
Cap/Sales 7.98%
Interest Coverage N/A
Cash Conversion 152.16%
Profit Quality N/A
Current Ratio 1.75
Quick Ratio 1.75
Altman-Z -0.19
F-Score3
WACC9.52%
ROIC/WACCN/A
Cap/Depr(3y)14.76%
Cap/Depr(5y)11.57%
Cap/Sales(3y)3.27%
Cap/Sales(5y)3.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-37.5%
EPS Next Y-35.98%
EPS Next 2Y-13.05%
EPS Next 3Y-4.6%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.05%
Revenue growth 3Y14.91%
Revenue growth 5Y24.15%
Sales Q2Q%-6.76%
Revenue Next Year-5.34%
Revenue Next 2Y-1.9%
Revenue Next 3Y-0.92%
Revenue Next 5YN/A
EBIT growth 1Y71.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-12.62%
EBIT Next 3Y-3.56%
EBIT Next 5YN/A
FCF growth 1Y70.85%
FCF growth 3Y35.38%
FCF growth 5Y18.42%
OCF growth 1Y83.35%
OCF growth 3Y32.16%
OCF growth 5Y21.93%